Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong

Victor Yung Sin Chow, Wing I Cheung

Open source

DOI
10.1186/s12876-023-03099-2
Published
2024-01-25
Container
BMC Gastroenterology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12876-023-03099-2,
  title = {Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong},
  author = {Victor Yung Sin Chow and Wing I Cheung},
  year = {2024},
  journal = {BMC Gastroenterology},
  doi = {10.1186/s12876-023-03099-2},
  url = {https://doi.org/10.1186/s12876-023-03099-2}
}

RIS

TY  - JOUR
TI  - Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong
AU  - Victor Yung Sin Chow
AU  - Wing I Cheung
PY  - 2024
JO  - BMC Gastroenterology
DO  - 10.1186/s12876-023-03099-2
UR  - https://doi.org/10.1186/s12876-023-03099-2
ER  - 

APA

Chow, V. Y. S., & Cheung, W. I. (2024). Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong. BMC Gastroenterology. https://doi.org/10.1186/s12876-023-03099-2

Source records